Hospira Wins European Backing For Generic Remicade; Shares Up
June 28, 2013 at 13:04 PM EDT
Good news from European regulators has helped drug maker Hospira (HSP) hit a new 52-week high. At $38, the stock climbed 5.2%, or $1.87, after earlier climbing as high as $38.50 after the company drew one-step closer in its bid to win European approval to a generic version of Johnson & Johnson’s (JNJ) blockbuster arthritis drug Remicade. [...]
